id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-D-0286-0015,FDA,FDA-2013-D-0286,Formal Meetings Between the FDA and Biosimilar Biological Product Sponsors or Applicants Guidance for Industry,Other,Guidance,2015-11-18T05:00:00Z,2015,11,2015-11-18T05:00:00Z,,2024-11-07T23:32:01Z,,1,0,0900006481d56471
FDA-2013-D-0286-0014,FDA,FDA-2013-D-0286,"Formal Meetings Between the Food and Drug Administration and
Biosimilar Biological Product Sponsors or Applicants; Guidance for
Industry; Availability",Notice,Notice of Availability,2015-11-18T05:00:00Z,2015,11,2015-11-18T05:00:00Z,,2015-11-18T16:29:20Z,2015-29455,0,0,0900006481d54890
FDA-2013-D-0286-0013,FDA,FDA-2013-D-0286,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approval; Guidance for Industry on Formal
Meetings Between the Food and Drug Administration and Biosimilar
Biological Product Sponsors or Applicants",Notice,Notice of Approval,2015-10-29T04:00:00Z,2015,10,2015-10-29T04:00:00Z,,2015-10-29T14:15:19Z,2015-27558,0,0,0900006481cf8adf
FDA-2013-D-0286-0012,FDA,FDA-2013-D-0286,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Comment Request; Guidance for
Industry on Formal Meetings Between the Food and Drug Administration and Biosimilar Biological Product Sponsors or Applicants",Notice,30 Day Proposed Information Collection,2015-06-05T04:00:00Z,2015,6,2015-06-05T04:00:00Z,2015-07-07T03:59:59Z,2015-06-05T15:03:49Z,2015-13695,0,0,0900006481b1ccd1